EDGAR Filing Documents for 0001193125-16-644957

Form 8-K - Current report:

SEC Accession No. 0001193125-16-644957

Filing Date

2016-07-11

Accepted

2016-07-11 08:01:49

Documents

Period of Report

2016-07-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d220825d8k.htm	8-K	29269
2	EX-2.1	d220825dex21.htm	EX-2.1	370876
3	EX-99.1	d220825dex991.htm	EX-99.1	19339
4	GRAPHIC	g220825pic01.jpg	GRAPHIC	25442
	Complete submission text file	0001193125-16-644957.txt		455983

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604

Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 161760776
SIC: 2834 Pharmaceutical Preparations